Public Trust Tracker Search

INV-082 · Money & ethics · Family business

Trump sons' fund and federal Ebola screening contracts for XpresTest

Stage 1 of 5: Reported · News reporting only · Last development 9 Nov 2026

ProPublica reports that XpresTest, a subsidiary of XWELL, received a CDC contract for Ebola entry screening and a State Department award for the Congo outbreak response in 2026, after a fund launched by Dominari Holdings, in which Donald Trump Jr. and Eric Trump hold a stake of more than 10%, invested in XWELL.

Reported by ProPublica; no official inquiry or finding so far. The companies and the State Department say the awards were competitive. Amounts are listed separately.

Photo of Donald Trump Jr.Photo of Eric Trump
People
Donald Trump Jr., Eric Trump, XpresTest, Dominari Holdings
Agencies
HHS (CDC), State Dept
Reviewed by
Press

Money involved

  • $18.8 million CDC contract to XpresTest for Ebola entry screening (Taxpayer money in questioned contracts, loans and funds) [1]
  • $20 million State Department award to XpresTest for the Congo Ebola response (Taxpayer money in questioned contracts, loans and funds, estimate) [1]
  • $30 million Dominari-launched fund's reported investment in XWELL, XpresTest's parent, not a payment to the Trumps (Other amounts, not totaled, estimate) [1]

Timeline

  1. ProPublica reports the two awards and the Dominari fund's investment in XWELL. The CDC did not respond to ProPublica. [1]

  2. The State Department awards XpresTest about $20 million for the response to the Ebola outbreak in the Democratic Republic of Congo. [1]

  3. The CDC awards XpresTest an $18.8 million contract for "Ebola entry screening services". [1]

  4. American Ventures, a fund launched by Dominari Holdings, invests about $30 million in XWELL, the parent company of XpresTest. Donald Trump Jr. and Eric Trump are advisers to Dominari and hold a stake of more than 10% in it. [1]

Responses

  • Spokesperson for Donald Trump Jr. and Eric Trump: They are "merely passive, minority investors in a fund that invested in this company" and had no "involvement in or knowledge regarding the negotiation or procurement of any of its contracts." [1]
  • State Department: The award was made "through a competitive process that builds on this successful model." [1]
  • Dominari CEO Anthony Hayes: "We have never seen or even heard of Don or Eric using their family name to influence" government contracts. [1]

Sources

  1. ProPublica, 9 Nov 2026

Cite this case

Public Trust Tracker. "Trump sons' fund and federal Ebola screening contracts for XpresTest" (INV-082). Last updated 9 Nov 2026. https://publictrusttracker.org/case/inv-082-trump-sons-fund-and-federal-ebola-screening-contracts-for/

Suggest a fact check